The Daily Fuckup: May 12, 2020

Edition · May 12, 2020

The Daily Fuckup: May 12, 2020

A historical backfill edition on the day Trump-world kept trying to sell “reopening” while the public-health case for caution was still screaming from the witness table.

On May 12, 2020, the Trump-era covid message machine was in full self-inflicted contradiction mode. The administration was telling Congress it had a careful, science-based reopening plan even as its broader political operation kept pushing a faster return to normal and downplaying the costs of the outbreak. The result was a familiar Trump-world problem: the more officials insisted everything was under control, the more the day’s own testimony and guidance showed how much was still not under control.

Closing take

May 12 was less a single explosion than a pileup of smaller collisions between spin, science, and reality. The day’s biggest screwups were the ones that made Trump’s preferred story harder to sustain: reopening was not simple, testing was still a mess, and the administration’s credibility was already paying the price.

Ranked by how bad the fuckup was

5 stars means maximum fallout. 1 star means a smaller self-own.

Story

Trump Team’s Reopen-Now Pitch Collides With the Public-Health Record

Reopen vs reality Confidence 4/5

★★★★☆Fuckup rating 4/5 Serious fuckup

The administration spent May 12 insisting it had a workable path back to normal, but the official record that day told a messier story. In congressional testimony, top health officials described a country still building the testing, tracing, and guidance systems needed for a safe reopening. That made the political rush to relaunch the economy look less like leadership and more like a pressure campaign against the science that was still trying to catch up.

Open story + comments

Story

FDA’s Remdesivir Update Exposes How Little of Trump’s Covid Playbook Was Settled

No finished playbook Confidence 4/5

★★★☆☆Fuckup rating 3/5 Major mess

Federal health officials pointed to a May 12 guideline update recommending remdesivir for certain hospitalized covid patients, but the announcement itself underscored how much was still being improvised. The administration wanted the day to read like momentum, yet the underlying reality was a response still dependent on emergency authorizations, preliminary data, and rapidly shifting guidance. That is useful progress, but it also shows why Trump-world’s “all under control” posture was so flimsy.

Open story + comments